Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2020 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Update on the classification and treatment of localized scleroderma.
Bielsa Marsol I. Bielsa Marsol I. Actas Dermosifiliogr. 2013 Oct;104(8):654-66. doi: 10.1016/j.adengl.2012.10.012. Epub 2013 Aug 13. Actas Dermosifiliogr. 2013. PMID: 23948159 Free article. Review.
Morphea or localized scleroderma is a distinctive inflammatory disease that leads to sclerosis of the skin and subcutaneous tissues. ...However, classification is difficult because the boundaries between the different types of morphea are blurred and different entit
Morphea or localized scleroderma is a distinctive inflammatory disease that leads to sclerosis of the skin and subcutaneous tissues.
Treatment in Juvenile Scleroderma.
Zulian F, Tirelli F. Zulian F, et al. Curr Rheumatol Rep. 2020 Jun 26;22(8):45. doi: 10.1007/s11926-020-00910-x. Curr Rheumatol Rep. 2020. PMID: 32591919 Review.
RECENT FINDINGS: According to the recent recommendations for Pediatric Rheumatology in Europe (SHARE), systemic treatment in localized scleroderma is needed when there is a risk for disability, such as in generalized or pansclerotic morphea and progressive linear sc …
RECENT FINDINGS: According to the recent recommendations for Pediatric Rheumatology in Europe (SHARE), systemic treatment in localized scler …
Evaluation of the Effectiveness and Tolerability of Mycophenolate Mofetil and Mycophenolic Acid for the Treatment of Morphea.
Arthur M, Fett NM, Latour E, Jacobe H, Kunzler E, Florez-Pollack S, Houser J, Sharma S, Prasad S, Femia A, Stern MJ, Pappas-Taffer LK, Gaffney R, Fernandez AP, Knabel D, Cardones AR, Leung N, Laumann A, Yu JM, Zhao J, Vleugels RA, Tkachenko E, Lo K. Arthur M, et al. JAMA Dermatol. 2020 May 1;156(5):521-528. doi: 10.1001/jamadermatol.2020.0035. JAMA Dermatol. 2020. PMID: 32236497 Free PMC article.
IMPORTANCE: First-line systemic therapy for morphea includes methotrexate with or without systemic corticosteroids. ...Generalized morphea (37 [48%]), pansclerotic morphea (12 [16%]), and linear morphea of the trunk and/or extremities (9 …
IMPORTANCE: First-line systemic therapy for morphea includes methotrexate with or without systemic corticosteroids. ...General …